| Expression pattern: |
UP |
| Associated gene: |
SOX4, COL1A1 |
| Associated microRNA: |
miR-338-3p |
| Biological function: |
Promotes bleomycin-induced pulmonary fibrosis; circHIPK3 knockdown reduces collagen deposition and myofibroblast markers in vivo. |
| Molecular mechanism: |
In vivo evidence supports circHIPK3 as a profibrotic regulator; knockdown decreases SOX4 and COL1A1 expression in bleomycin-induced fibrosis lungs. |
| Biological pathway or process: |
fibrosis (promotes); proliferation (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RNase R Treatment; RT-qPCR; Sanger Sequencing; divergent primers PCR; Transfection; Western Blot; IF (Immunofluorescence); In Vivo Animal Model; H&E Staining |
| Clinical significance: |
- |
| Description: |
Mouse circHIPK3 (mmu_circ_0001052) is up-regulated in bleomycin-induced pulmonary fibrosis lungs. In vivo knockdown reduces fibrotic collagen deposition and lowers SOX4/COL1A1 expression, supporting a profibrotic role. |
| Confidence score: |
0.6306 |